MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ — Sparta Biomedical, a private medical device company focused on osteoarthritis repair solutions, today announced that it has successfully implanted its Ormi device in patients with focal knee lesions as part of its first-in-human clinical trial. The ongoing prospective, multi-center, single-arm study is being conducted at sites in the Dominican Republic and Colombia, where patients have already been enrolled and treated.
Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi
